Skip to main content
. 2018 Jan 29;52:4. doi: 10.11606/S1518-8787.2018052000295

Table 1. Distribution of AEFI cases, number of doses administered, number of doses per case, and rate per 10,000 doses, according to vaccine and route of administration in children up to 24 months of age. Araraquara, state of São Paulo, Brazil, 2000 to 2013. (n = 565).

Variable Number of AEFI cases Total of doses Number of doses per case Rate per 10,000 doses
Vaccine
BCG 41 42,767 1,043 9.6
Hepatitis B 25 120,819 4,833 2.1
DTPw-Hib and Pentavalenta 252 102,689 407 24.5
DTPw 161 62,980 391 25.6
10/13V Pneumococcal Conjugate 28 45,903 1,639 6.1
Men-C-ACYW 17 36,289 2,135 4.7
IPVb 7 8,634 1,233 8.1
OPVc 47 158,367 3,369 3.0
Rotavirus 38 42,974 1,131 8.8
MMR 53 47,718 900 11.1
MMRVd 1 711 711 14.1
Influenza 15 26,152 1,743 5.7
Yellow fever 14 20,170 1,441 6.9
Route of administratione
Intramuscular 505 403,466 799 12.5
Intradermal 41 42,767 1,043 9.6
Subcutaneous 68 68,599 1,009 9.9
Oral 85 201,341 2,369 4.2
a

DTPw-Hib or tetravalent: diphtheria-tetanus-pertussis (whole-cell) and Haemophilus influenzae b. Pentavalent: diphtheria-tetanus-pertussis (whole-cell) and Haemophilus influenzae b and Hepatitis B.

b

IPV: inactivated polio vaccine.

c

OPV: oral polio vaccine.

d

MMRV: measles, mumps, rubella, and varicella.

e

The same individual may have more than one vaccine associated with AEFI.